19
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Use of Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio and Platelets-to-Lymphocyte Ratio in the Assessment of the Risk of Conversion and Complications After Cholecystectomy Performed Due to Symptomatic Cholelithiasis

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 363-371 | Received 09 Mar 2024, Accepted 28 May 2024, Published online: 14 Jun 2024

References

  • Sutcliffe RP, Hollyman M, Hodson J, et al. Preoperative risk factors for conversion from laparoscopic to open cholecystectomy: a validated risk score derived from a prospective UK database of 8820 patients. HPB. 2016;18(11):922.
  • Sippey M, Grzybowski M, Manwaring ML, et al. Acute cholecystitis: risk factors for conversion to an open procedure. J Surg Res. 2015;199(2):357–361. doi:10.1016/j.jss.2015.05.040
  • Goonawardena J, Gunnarsson R, De Costa A. Predicting conversion from laparoscopic to open cholecystectomy presented as a probability nomogram based on preoperative patient risk factors. Am J Surg. 2015;210(3):492–500. doi:10.1016/j.amjsurg.2015.04.003
  • Burke J, Rattan R, Sedighim S, Kim M. A simple risk score to predict Clavien-Dindo grade IV and V complications after non-elective cholecystectomy. J Gastrointest Surg. 2021;25(1):201. doi:10.1007/s11605-020-04514-9
  • Hanson-Viana E, Ayala-Moreno EA, Ortega-Leon LH, Montalvo-Javé EE. The association of preoperative risk factors for laparoscopic conversion to open surgery in elective cholecystectomy. Euroasian J Hepatogastroenterol. 2022;12(1):6. doi:10.5005/jp-journals-10018-1366
  • Rice CP, Vaishnavi KB, Schaeffer AB, et al. Operative complications and economic outcomes of cholecystectomy for acute cholecystitis. World J Gastroenterol. 2019;25(48):6916. doi:10.3748/wjg.v25.i48.6916
  • Ishizuka M, Shibuya N, Shimoda M, Kato M, Aoki T, Kubota K. Preoperative hypoalbuminemia is an independent risk factor for conversion from laparoscopic to open cholecystectomy in patients with cholecystolithiasis. Asian J Endosc Surg. 2016;9(4):275–280. doi:10.1111/ases.12301
  • Moloney BM, Waldron RM, O’ Halloran N, et al. The clinical utility of pre-operative neutrophil-to-lymphocyte ratio as a predictor of outcomes in patients undergoing elective laparoscopic cholecystectomy. Ir J Med Sci. 2018;187(3):755–760. doi:10.1007/s11845-018-1749-6
  • Zhu S, Yang J, Cui X, et al. Preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as predictors of clinical outcome in patients with gallbladder cancer. Sci Rep. 2019;9(1):1–9. doi:10.1038/s41598-018-37186-2
  • Deng Y, Zhang F, Yu X, Huo CL, Sun ZG, Wang S. Prognostic value of preoperative systemic inflammatory biomarkers in patients with gallbladder cancer and the establishment of a nomogram. Cancer Manag Res. 2019;11:9025–9035. doi:10.2147/CMAR.S218119
  • Kucuk S, Mızrak S. Diagnostic value of inflammatory factors in patients with gallbladder cancer, dysplasia, and cholecystitis. Cancer Contr. 2021;28:10732748211033746.
  • Mayhew D, Mendonca V, Murthy BVS. A review of ASA physical status - historical perspectives and modern developments. Anaesthesia. 2019;74(3):373–379. doi:10.1111/anae.14569
  • Clavien PA, Barkun J, De Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–196. doi:10.1097/SLA.0b013e3181b13ca2
  • Izumisawa Y, Morioka D, Fuse M, et al. Defining the term “Elderly” in the field of surgery: a retrospective study regarding the changes in the immunoinflammatory indices during the immediate perioperative period of the elective uncomplicated laparoscopic cholecystectomy. Surg Laparosc Endosc Percutan Tech. 2020;30(5):435. doi:10.1097/SLE.0000000000000803
  • Lee SK, Lee SC, Park JW, Kim SJ. The utility of the preoperative neutrophil-to-lymphocyte ratio in predicting severe cholecystitis: a retrospective cohort study. BMC Surg. 2014;14(1). doi:10.1186/1471-2482-14-100
  • Durak D, Alkurt EG, Tutan MB. CRP, WBC and monocyte/lymphocyte ratio relation as a preoperative predictive factor for adhesions observed during laparoscopic cholecystectomy. J Health Sci Med. 2021;4(5):686–691. doi:10.32322/jhsm.952507
  • Ares JÁD, García RM, Vidagany NE, et al. Can inflammatory biomarkers help in the diagnosis and prognosis of gangrenous acute cholecystitis? A prospective study. Rev Esp Enferm Dig. 2021;113(1):41–44. doi:10.17235/reed.2020.7282/2020
  • Ahmed SE, Rehman S, Edilbe M, Jonker L, Canelo R. Can neutrophil-lymphocyte ratio predict operators’ difficulty in early cholecystectomies; a retrospective cohort study. Ann Emerg Surg. 2017;2(3):1016.
  • Shimoda M, Udo R, Imasato R, Oshiro Y, Suzuki S. What are the risk factors of conversion from total cholecystectomy to bailout surgery? Surg Endosc. 2021;35(5):2206–2210. doi:10.1007/s00464-020-07626-0
  • Okamoto K, Suzuki K, Takada T, et al. Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25(1):55–72. doi:10.1002/jhbp.516
  • Gupta R, Khanduri A, Singh A, et al. Defining critical view of safety during laparoscopic cholecystectomy: the preoperative predictors of failure. Cureus. 2023;15(4):1–8. doi:10.7759/cureus.37464
  • Bouassida M, Zribi S, Krimi B, et al. C-reactive protein is the best biomarker to predict advanced acute cholecystitis and conversion to open surgery. a prospective cohort study of 556 cases. J Gastrointest Surg. 2020;24(12):2766–2772. doi:10.1007/s11605-019-04459-8
  • Kubat M, Şengül S, Şahin S. Efficacy of blood parameters as indicators of the need for overdue urgent cholecystectomy in elderly patients with acute cholecystitis. Ulus Travma Acil Cerrahi Derg. 2023;29(11):1248–1254. doi:10.14744/tjtes.2023.75670
  • Kartal M, Kalaycı T. Can neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, prognostic nutrition index, and albumin be used to predict cholecystectomy morbidity in super-elderly patients? Turk J Trauma Emerg Surg. 2023;29(8):890.